Clinical Trial Update: Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance therapy with Gleevec (imatinib) after induction irinotecan and cisplatin in patients with C-KIT positive extensive small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Gleevec (Imatinib)
• Platinol (cisplatin)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED